What Repligen Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 7 | 25 |
| Total trades | 17 | 69 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 28,700 | 120,336 |
| Disposed | 37,156 | 117,588 |
| Net activity | −8,456 | +2,748 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Douglass Brian Robb | CHIEF PRODUCT OFFICER | Oct 06 | Grant / award · A | +700 | — | — | 8,685 |
| Loeillot Olivier | Chief Executive Officer | Oct 05 | Disclosed 10b5-1 sale · S | −4,202 | $190.00 | −$798K | 45,788 |
| Loeillot Olivier | Chief Executive Officer | Oct 05 | Exercise / conversion · M | +4,202 | $154.96 | +$651K | 49,990 |
| Loeillot Olivier | Chief Executive Officer | Oct 05 | Disclosed 10b5-1 sale · S | −1,333 | $178.75 | −$238K | 45,788 |
| Loeillot Olivier | Chief Executive Officer | Oct 02 | Withheld — tax / exercise cost · F | −1,248 | $181.70 | −$227K | 47,121 |
| Garland Jason K | CFO | Sep 25 | Withheld — tax / exercise cost · F | −421 | $189.68 | −$79.9K | 18,408 |
| Loeillot Olivier | Chief Executive Officer | Sep 24 | Disclosed 10b5-1 sale · S | −4,542 | $190.00 | −$863K | 48,369 |
| Loeillot Olivier | Chief Executive Officer | Sep 24 | Exercise / conversion · M | +4,542 | $155.38 | +$706K | 52,911 |
| Loeillot Olivier | Chief Executive Officer | Sep 24 | Disclosed 10b5-1 sale · S | −8,404 | $190.00 | −$1.6M | 48,369 |
| Loeillot Olivier | Chief Executive Officer | Sep 24 | Exercise / conversion · M | +8,404 | $154.96 | +$1.3M | 56,773 |
| Loeillot Olivier | Chief Executive Officer | Sep 21 | Disclosed 10b5-1 sale · S | −5,426 | $180.00 | −$977K | 48,369 |
| Loeillot Olivier | Chief Executive Officer | Sep 21 | Exercise / conversion · M | +5,426 | $141.79 | +$769K | 53,795 |
| Loeillot Olivier | Chief Executive Officer | Sep 04 | Disclosed 10b5-1 sale · S | −3,035 | $165.90 | −$504K | 48,369 |
| Loeillot Olivier | Chief Executive Officer | Sep 03 | Withheld — tax / exercise cost · F | −2,842 | $169.61 | −$482K | 51,404 |
| Hughes Violetta | CHIEF ACCOUNTING OFFICER | Sep 01 | Withheld — tax / exercise cost · F | −277 | $170.02 | −$47.1K | 6,331 |
| Loeillot Olivier | Chief Executive Officer | Aug 20 | Disclosed 10b5-1 sale · S | −5,426 | $180.00 | −$977K | 54,246 |
| Loeillot Olivier | Chief Executive Officer | Aug 20 | Exercise / conversion · M | +5,426 | $141.79 | +$769K | 59,672 |
| Garland Jason K | CFO | Jul 16 | Disclosed 10b5-1 sale · S | −530 | $150.00 | −$79.5K | 18,829 |
| Garland Jason K | CFO | Jun 25 | Disclosed 10b5-1 sale · S | −733 | $145.00 | −$106K | 19,359 |
| Madaus Martin D | Director | May 14 | Grant / award · A | +995 | — | — | 6,581 |
Loading...
